Clinical Trial Update: A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACS [Phase 4]

View source ↗

Summary

Phase IV study evaluating the onset and maintenance of ticagrelor’s antiplatelet effect compared with clopidogrel in Chinese patients with acute coronary syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-elevation Acute Coronary Syndrome
• St-elevation Acute Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Non-ST or ST Elevation Acute Coronary Syndromes | Phase 4 | Status: COMPLETED | Results posted: 2015-03-02